Laura San Segundo Payo-rekin lankidetzan egindako argitalpenak (5)

2017

  1. C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis

    Oncotarget, Vol. 8, Núm. 67, pp. 110994-111011

2016

  1. Effect of mTORC1/mTORC2 inhibition on T cell function: Potential role in graft-versus-host disease control

    British Journal of Haematology, Vol. 173, Núm. 5, pp. 754-768

  2. Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

    Journal of Hematology and Oncology, Vol. 9, Núm. 1

2015

  1. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

    Leukemia, Vol. 29, Núm. 5, pp. 1186-1194

2013

  1. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

    Blood, Vol. 122, Núm. 22, pp. 3591-3598